These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31512991)

  • 1. Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system.
    Reynolds K; Mues KE; Harrison TN; Qian L; Chen S; Hsu JY; Philip KJ; Monda KL; Reading SR; Brar SS
    Vasc Med; 2020 Feb; 25(1):3-12. PubMed ID: 31512991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of lower extremity peripheral artery disease in veterans.
    Willey J; Mentias A; Vaughan-Sarrazin M; McCoy K; Rosenthal G; Girotra S
    J Vasc Surg; 2018 Aug; 68(2):527-535.e5. PubMed ID: 29588132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis.
    Kokkinidis DG; Arfaras-Melainis A; Giannopoulos S; Katsaros I; Jawaid O; Jonnalagadda AK; Parikh SA; Secemsky EA; Giri J; Kumbhani DJ; Armstrong EJ
    Vasc Med; 2020 Apr; 25(2):106-117. PubMed ID: 31964311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.
    Mahtta D; Ahmed ST; Ramsey DJ; Akeroyd JM; Lee MT; Rodriguez F; Michos ED; Itchhaporia D; Nasir K; Alam M; Jneid H; Ballantyne CM; Petersen LA; Virani SS
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):745-754. PubMed ID: 32840709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.
    O'Donnell TFX; Deery SE; Darling JD; Shean KE; Mittleman MA; Yee GN; Dernbach MR; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):572-578. PubMed ID: 28506476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease.
    Foley TR; Singh GD; Kokkinidis DG; Choy HK; Pham T; Amsterdam EA; Rutledge JC; Waldo SW; Armstrong EJ; Laird JR
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.
    Khariton Y; Patel KK; Chan PS; Pokharel Y; Wang J; Spertus JA; Safley DM; Hiatt WR; Smolderen KG
    Clin Cardiol; 2018 Nov; 41(11):1414-1422. PubMed ID: 30284297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol.
    Harrison TN; Scott RD; Cheetham TC; Chang SC; Hsu JY; Wei R; Ling Grant DS; Boklage SH; Romo-LeTourneau V; Reynolds K
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):397-404. PubMed ID: 30062465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.
    Bin Abdulhak AA; Vaughan-Sarrzin M; Kaboli P; Horwitz PA; Mosher H; Sigurdsson G; Walker NE; Wallace R; Robinson JG
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29503265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Suboptimal Utilization of Statins and Antiplatelet Therapy in Patients Undergoing Revascularization for Symptomatic Peripheral Arterial Disease.
    Meltzer AJ; Sedrakyan A; Connolly PH; Ellozy S; Schneider DB;
    Ann Vasc Surg; 2018 Jan; 46():234-240. PubMed ID: 28602895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
    Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
    J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The real-world data of lipid-lowering treatment in patients with peripheral artery disease and its association with severity of disease.
    Komai H; Ogura M; Sakashita H; Miyama N; Yamamoto N; Takai K; Hatada A; Tanimura N; Nakamura T; Yoshida M; Kawaura T; Kitawaki T;
    J Cardiol; 2024 Jul; 84(1):36-40. PubMed ID: 37816481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral atherectomy practice patterns in the United States from the Vascular Quality Initiative.
    Mohan S; Flahive JM; Arous EJ; Judelson DR; Aiello FA; Schanzer A; Simons JP;
    J Vasc Surg; 2018 Dec; 68(6):1806-1816. PubMed ID: 29937287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG; Wang TY; Xiang Q; Goldberg AC; Robinson JG; Roger VL; Virani SS; Wilson PWF; Louie MJ; Koren A; Li Z; Peterson ED; Navar AM
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).
    Liu Y; Lv X; Xie N; Fang Z; Ren W; Gong Y; Jin Y; Zhang J
    BMC Cardiovasc Disord; 2020 Apr; 20(1):201. PubMed ID: 32334525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
    McBride CL; Akeroyd JM; Ramsey DJ; Nambi V; Nasir K; Michos ED; Bush RL; Jneid H; Morris PB; Bittner VA; Ballantyne CM; Petersen LA; Virani SS
    Vasc Med; 2018 Jun; 23(3):232-240. PubMed ID: 29600737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
    Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
    Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.